As of Feb 27
| +0.41 / +3.26%|
The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 18.50, with a high estimate of 23.00 and a low estimate of 18.00. The median estimate represents a +42.42% increase from the last price of 12.99.
The current consensus among 4 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.